Treatment groups | No. zygotes | First cleavage 48 hpi (%) | Morula rate (%) | Blastocyst rate (%) |
---|---|---|---|---|
miR-130b precursor | 490 | 77.1 ± 5.1 | 32.7 ± 3.8a | 28.1 ± 2.2a |
miR-130b inhibitor | 451 | 76.1 ± 0.9 | 23.2 ± 2.5b | 21.3 ± 1.9b |
Scramble miRNA | 454 | 79.9 ± 1.2 | 27.3 ± 3.8ab | 25.9 ± 3.1a |
Uninjected control | 326 | 79.4 ± 5.1 | 32.7 ± 2.4a | 27.2 ± 2.6a |